hTERT-HME1 [ME16C]
CRL-4010 ™
Explore our data Learn about ways to access our datahTERT-HME1 [ME16C] are hTERT-immortalized cells exhibiting epithelial morphology that were isolated from the breasts of a 53-year-old female patient undergoing reduction mammoplasty surgery (no history of breast cancer). This cell line has applications in drug development, high-throughput screening, and quality control.
For‑profit customers intending to use this product for non-commercial screening must include the one-time “ATCC Screening Fee” (ATCC® ACS‑2103F) with their first purchase of this product.